Title |
Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?
|
---|---|
Published in |
International Journal of Cancer, June 2014
|
DOI | 10.1002/ijc.29003 |
Pubmed ID | |
Authors |
Ronan F. Downey, Francis J. Sullivan, Feng Wang-Johanning, Stefan Ambs, Francis J. Giles, Sharon A. Glynn |
Abstract |
Harbored as relics of ancient germline infections, human endogenous retroviruses (HERVs) now constitute up to 8% of our genome. A proportion of this sequence has been co-opted for molecular and cellular processes, beneficial to human physiology, such as the fusogenic activity of the envelope protein, a vital component of placentogenesis. However, the discovery of high levels of HERV-K mRNA and protein and even virions in a wide array of cancers, has revealed that HERV-K may be playing a more sinister role - a role as an etiological agent in cancer itself. Whether the presence of this retroviral material is simply an epiphenomenon, or an actual causative factor, is a hotly debated topic. This review will summarize the current state of knowledge regarding HERV-K and cancer and attempt to outline the potential mechanisms by which HERV-K could be involved in the onset and promotion of carcinogenesis. © 2014 Wiley Periodicals, Inc. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Ireland | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
Brazil | 1 | <1% |
Canada | 1 | <1% |
Belgium | 1 | <1% |
United States | 1 | <1% |
Unknown | 161 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 31 | 19% |
Student > Master | 30 | 18% |
Researcher | 26 | 16% |
Student > Bachelor | 23 | 14% |
Student > Postgraduate | 11 | 7% |
Other | 25 | 15% |
Unknown | 20 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 44 | 27% |
Biochemistry, Genetics and Molecular Biology | 35 | 21% |
Medicine and Dentistry | 31 | 19% |
Immunology and Microbiology | 12 | 7% |
Engineering | 5 | 3% |
Other | 13 | 8% |
Unknown | 26 | 16% |